Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy

Madiha Iqbal, Deepa Jagadeesh, Julio Chavez, Arushi Khurana, Allison Rosenthal, Emily Craver, Narendranath Epperla, Zhuo Li, Iris Isufi, Farrukh T. Awan, Bhagirathbhai R. Dholaria, Joseph E. Maakaron, Jose D. Sandoval-Sus, Rahul Mishra, Aditi Saha, Kaitlin Annunzio, Shakthi T. Bhaskar, Nuttavut Sumransub, Andrew Fijalka, Stanislav A. IvanovYi Lin, Mohamed A. Kharfan-Dabaja

IM-Hem Onc BMT
Internal Medicine

Research output: Contribution to journal › Article › peer-review

Sort by
Weight
Alphabetically

Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy

Fingerprint

Medicine & Life Sciences